CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review. (2023). American Journal of Medical Science and Innovation, 2(2), 44-56. https://doi.org/10.54536/ajmsi.v2i2.1760